January 7, 2007 |
EVERY YEAR SINCE 1996, the online salon Edge has e-mailed a question to scientists and thinkers about the state of the world. This year's question was: "What are you optimistic about?" Below are excerpts of some of the responses. For full responses (and those of other contributors), go to www.edge.org.
January 23, 2002 |
J. Craig Venter, the maverick scientist whose drive to crack the human genome ignited one of the fiercest rivalries in modern science, resigned Tuesday from the company he helped launch, Celera Genomics. Venter's abrupt departure from the high-profile gene-mapping company prompted speculation that he left under pressure from Celera's parent, Applera Corp. No successor to Venter was named.
December 13, 2000 |
Leaders of the publicly led drive to crack the human genetic code have quietly refused to submit the research paper describing their findings to the same scientific journal as their private-sector rivals, puncturing a truce announced with great fanfare in June by President Clinton. The move revives one of the fiercest rivalries of modern science, which pits the publicly led Human Genome Project against biotech upstart Celera Genomics.
June 27, 2000 |
Everybody has a particular way of entering a room. Francis Collins' is to come in quietly behind controversial figures. In 1992, Collins took charge of the publicly led Human Genome Project after James D. Watson, the voluble co-discoverer of DNA's structure, quit in a spat with his government superiors. He was pushed farther into the limelight when J. Craig Venter, the mercurial president of Celera Genomics, announced his determination to beat Collins' team to cracking the genetic code.
December 8, 2000 |
The prestigious journal Science is on the verge of striking an unusual bargain: In return for the right to publish a path-breaking paper on the human genetic code, it would allow the paper's biotech company authors to make their supporting data accessible only to those who promise not to use them for commercial or certain other purposes.
April 5, 2000 |
Monsanto Co. said Tuesday that it has completed "a working draft" of the genetic code of the rice plant--paving the way for improved nutrition, crop yields and drought tolerance, traits needed to feed a growing world population. It is the first plant genome to reach this advanced stage of completion, and scientists say it is especially significant because almost half of the world's people, most of them in Asia, depend on rice as the main staple in their diet.
April 7, 2000 |
A biotech company announced Thursday that it has deciphered the genome of a human volunteer, claiming a scientific first that was greeted by both praise and skepticism from academic scientists who point out that the job remains unfinished. Celera Genomics, in a race with a public effort to map the human genetic code, said it has decoded millions of DNA fragments extracted from an anonymous person--the first phase of its effort to put together a so-called working draft of the genome.
CALIFORNIA | LOCAL
April 11, 1994
The early discoverers of and experimenters with electricity could hardly have imagined how their work would ultimately transform the world. A similar technological upheaval awaits us now as private business starts to exploit the revolution in molecular biology to bring new cures, therapies and we-know-not-what. Just four decades after James D. Watson and Francis H. C.
January 11, 2000 |
A private company that is racing to be the first to map the human genome claimed Monday that it has now deciphered more than 90% of the material that goes into the human genetic code--a signal that the search for the Holy Grail of biotechnology is likely to be completed in a matter of months. Celera Genomics Group, a Rockville, Md., subsidiary of PE Corp., said it expects to have a "rough draft" of the entire code by early summer.
June 28, 2000 |
A day after President Clinton and leading scientists warned that the great achievement of deciphering human DNA also could lead to discrimination, Republican aides in Congress said that there is no need to pass anti-discrimination protections this year. Improvements in genetic testing have allowed doctors to determine whether someone has an elevated risk of developing breast cancer, colon cancer or certain other diseases, years before symptoms appear.